المؤلفون: Šandrk, Marina

المساهمون: Božina, Nada

مصطلحات موضوعية: CYP3A4, DOAC, gene polymorphisms CES1, apixaban, rivaroksaban, edoksaban, ABCB2, genski polimorfizmi CES1, apiksaban, DOAK, P-glycoprotein MDR1 / ABCB1, direct oral anticoagulants, P-glikoprotein, BIOMEDICINE AND HEALTHCARE. Pharmacy. Pharmacy, direktni oralni antikoagulansi, edoxaban, farmakogenetika, dabigatran, MDR1/ABCB1, BIOMEDICINA I ZDRAVSTVO. Farmacija. Farmacija, rivaroxaban, pharmacogenetics

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3671::259ffd1a01a1770c16c7362b8f851b30
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:2723/datastream/PDF

المؤلفون: Vršić, Paula

المساهمون: Salarić, Ivan

مصطلحات موضوعية: BIOMEDICINE AND HEALTHCARE. Dental Medicine. Oral Surgery, Hemostasis, krvarenje, Oral Surgical Procedures, oralnokirurški postupci, hemostaza, antikoagulantni lijekovi, dabigatran, rivaroksaban, apiksaban, edoksaban, oralna kirurgija, Anticoagulants, Hemorrhage, antikolagulansi, BIOMEDICINA I ZDRAVSTVO. Dentalna medicina. Oralna kirurgija

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9d947961009151d3e514bfdd1208d147
https://repozitorij.sfzg.unizg.hr/islandora/object/sfzg:1330/datastream/PDF

المؤلفون: Janžič, Andrej

المساهمون: Kos, Mitja

مصطلحات موضوعية: vrednotenje, antikoagulacijske ambulante, antikoagulanti, stroškovna učinkovitost, ekonomska učinkovitost, organiziranost, genotipizacija, doktorske disertacije, rivaroksaban, dabigatran eteksilat, udc:616.151.5-085:336.532.2(043.3), apiksaban, zdravstvena tehnologija, farmakoekonomika, varfarin, kakovost življenja, medicina

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3505::2e078f9c876af97eae505e41179ffeba
https://hdl.handle.net/20.500.12556/RUL-137422

المؤلفون: Lučić, Darija

المساهمون: Božina, Nada

مصطلحات موضوعية: CYP3A5, CYP3A4, ABCG2, direct oral anticoagulans, apixaban, SNP, apiksaban, novi oralni antikoagulansi, BIOMEDICINE AND HEALTHCARE. Pharmacy. Pharmacy, tromboembolijski događaji, direktni oralni antikoagulansi, oral anticoagulans, interakcije gen-lijek, farmakogenetika, CES1, dabigatran, transporter gene polymorphysm, BIOMEDICINA I ZDRAVSTVO. Farmacija. Farmacija, rivaroxaban, pharmacogenetics, tromboembolic events, pharmacogenomics, polimorfizam gena transportera ABCB1, interakcije lijek-lijek, interactions gen-drug, edoksaban, rivaroksaban, ABCB1, farmakogenomika, bleeding, genske varijante, krvarenje, edoxaban, interactions drug-drug, novel oral anticoagulans, genetic variations

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3671::011416fb20fb8034aea4221f041b98f7
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:2481/datastream/PDF

المؤلفون: Authén, Julia Ann

المصدر: Authén, Julia Ann. Direktevirkende perorale antikoagulantia - en oversikt med vekt på bivirkninger. Master thesis, University of Oslo, 2018

الإتاحة: http://hdl.handle.net/10852/68518
https://www.duo.uio.no/bitstream/handle/10852/68518/1/Masteropppgave-S-roppgave-28-09-2018.pdf

المؤلفون: Katarina Nastić, Radica Stepanović-Petrović

المصدر: Arhiv za farmaciju, Vol 70, Iss 5, Pp 249-268 (2020)
Arhiv za farmaciju

مصطلحات موضوعية: apixaban, Pharmaceutical Science, lcsh:RS1-441, 030204 cardiovascular system & hematology, apiksaban, direct oral anticoagulants, Dabigatran, lcsh:Pharmacy and materia medica, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Edoxaban, direktni oralni antikoagulansi, medicine, dabigatran, betrixaban, rivaroxaban, betriksaban, Pharmacology, Rivaroxaban, business.industry, Warfarin, rivaroksaban, edoksaban, 3. Good health, chemistry, Direct thrombin inhibitor, 030220 oncology & carcinogenesis, Anesthesia, Betrixaban, edoxaban, Apixaban, business, Andexanet alfa, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c2a5ed878669e36b5949a915f6b43c
https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2020/0004-19632005249S.pdf

المؤلفون: Dopsaj Violeta

المصدر: Arhiv za farmaciju
Arhiv za farmaciju, Vol 70, Iss 5, Pp 297-309 (2020)

مصطلحات موضوعية: Drug, medicine.medical_specialty, DOAC, media_common.quotation_subject, apixaban, lcsh:RS1-441, Pharmaceutical Science, apiksaban, 030204 cardiovascular system & hematology, Dabigatran, lcsh:Pharmacy and materia medica, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, laboratorijsko praćenje, Edoxaban, Antithrombotic, Medicine, dabigatran, Intensive care medicine, rivaroxaban, doacs, media_common, Pharmacology, Rivaroxaban, business.industry, rivaroksaban, laboratory monitoring, Atrial fibrillation, DOACs, medicine.disease, 3. Good health, chemistry, 030220 oncology & carcinogenesis, Hemostasis, Apixaban, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed852803df9cc0001b3c520b04dc6ca
https://doi.org/10.5937/arhfarm2005297d

المؤلفون: Mehmet Onur Omaygenç, Derya Özden Omaygenç

مصطلحات موضوعية: Hemothorax, Hemotoraks, medicine.medical_specialty, Anticoagulant Agents, business.industry, Pleural effusion, Atrial fibrillation, Plevral Efüzyon, medicine.disease, Hemorrhagic pleural effusion, Surgery, Pleural Effusion, Antikoagülan Ajanlar, Atrial Fibrillation, Atriyal Fibrilasyon, medicine, Anticoagulant Agent, Apixaban, Apiksaban, Cardiology and Cardiovascular Medicine, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37356101f3f7eb2e09ee8c09a59a54e6
https://hdl.handle.net/20.500.12511/9255

المؤلفون: Šinigoj, Petra

المساهمون: Mavri, Alenka

مصطلحات موضوعية: koncentracija zdravila, koagulacijske preiskave, atrijska fibrilacija, apixaban, rivaroksaban, blood coagulation tests, drug concentration, dabigatran, atrial fibrillation, apiksaban, rivaroxaban

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3505::85f1b148f9d8d99f9440498754351b7a
https://repozitorij.uni-lj.si/Dokument.php?id=113213&dn=

المؤلفون: Michał Witkowski, Piotr Smolewski, Magdalena Witkowska

المصدر: Postępy Higieny i Medycyny Doświadczalnej, Vol 70, Pp 43-55 (2016)

مصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Pyridines, Pyridones, rywaroksaban, Administration, Oral, lcsh:Medicine, Routine practice, Vitamin k, apiksaban, Dabigatran, anticoagulant treatment, 03 medical and health sciences, chemistry.chemical_compound, Rivaroxaban, Edoxaban, medicine, Humans, nowe leki przeciwkrzepliwe, dabigatran, Risks and benefits, Practice Patterns, Physicians', Intensive care medicine, business.industry, lcsh:R, migotanie przedsionków, edoksaban, Anticoagulants, Thiazoles, 030104 developmental biology, Infectious Diseases, chemistry, Anticoagulant therapy, Pyrazoles, Apixaban, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6de880e7bc6f243f4ef34d0036836e
http://phmd.pl/gicid/pdf/01.3001.0009.6782